Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
-
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
-
GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing
-
Cyabra to Participate in the 27th Annual Needham Growth Conference on January 17
-
BitFuFu Signs Two-Year Framework Agreement with BITMAIN for 80,000 Miners
-
Lexicon Appoints Scott Coiante as Chief Financial Officer
-
SEFA Rebrands to Heidelberg Materials
-
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
Gentex Promotes Boehm to Chief Operations Officer
-
MICA Announces $16 Million Dividend
-
Justin Wohl Joins Aditude as Vice President of Strategy, Focusing on Open Internet Software Solutions
-
GlobalFoundries and IBM Announce Settlement and Resolution of All Litigation Matters
-
Provident Financial Services, Inc. Schedules Fourth Quarter and Year-End Earnings Conference Call
-
Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
-
Trustee appointed for the arbitration proceedings concerning the redemption of minority shares in Innofactor Plc
-
Arbe to Present at 27th Annual Needham Growth Conference
-
Form 8.3 - Learning Technologies Group Plc - Octopus Investments
-
Intesa Sanpaolo leads the Eurozone by market capitalisation
-
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
-
Yuewen Music Festival Lights Up Singapore Sky with Drone and Firework Spectacle in 2025 Countdown
-
Canadian Gold Resources (TSXV: CAN) Announces Closing of Non-Brokered Private Placement of Flow-Through Units and Non Flow-Through Units
-
CoinsDo Issues Warning Against Impersonation and Scam Websites
-
Prime Drink Group Announces Closing of First Tranche of Private Placement and Change of Fiscal Year-End
-
Watsco Declares $2.70 Quarterly Dividend
-
ZenaTech Opens a Beyond Visual Line of Sight (BVLOS) Drone Testing Facility in Turkey for US Defense and NATO-Destined ZenaDrone 1000 Drones
-
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
-
LeddarTech Showcases LeddarVision Surround-View ADAS AI Platform Technology at CES 2025 in Las Vegas
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Building Digital Bridges: CoinEx Charity's Award-Winning Starlink Program
-
Building Digital Bridges: CoinEx Charity's Award-Winning Starlink Program
-
Invesco Ltd: Form 8.3 - PRS REIT PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Co; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Anfield Energy Inc. Provides Further Update on Proposed Plan of Arrangement
-
Kintavar enters Definitive Agreement to Sell the Fer à Cheval Outfitter
-
Bitfarms Provides December 2024 Production and Operations Update
-
Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics
-
Altus Group Completes the Sale of its Property Tax Business to Ryan, LLC
-
BioStem Technologies CEO to Present at Biotech Showcase 2025
-
Primior Holdings (GRLT) Q3 2024 Financial Results Exceed Market Expectations
-
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
-
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
-
HUB Cyber Security Updates on Strategic Share Registrations and Loan Securities
-
Digihost Increases Cash Flow Position and Revenues Year Over Year and Provides December 2024 Production Update
-
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
-
iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio
-
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
